As of 2025-06-02, the EV/EBITDA ratio of Tinavi Medical Technologies Co Ltd (688277.SS) is -58.34. EV/EBITDA ratio is calculated by dividing the enterprise value by the TTM EBITDA. 688277.SS's latest enterprise value is 6,108.45 mil CNY. 688277.SS's TTM EBITDA according to its financial statements is -104.71 mil CNY. Dividing these 2 quantities gives us the above 688277.SS EV/EBITDA ratio.
Note: valuation result may not be accurate due to the company's negative EBITDA.
| Range | Selected | |
| Trailing P/E multiples | 18.9x - 30.2x | 24.8x |
| Forward P/E multiples | 11.1x - 13.4x | 12.1x |
| Fair Price | (4.24) - 1.32 | (2.20) |
| Upside | -131.1% - -90.3% | -116.1% |
| Date | EV/EBITDA |
| 2025-03-04 | -60.63 |
| 2025-03-03 | -58.81 |
| 2025-02-28 | -58.77 |
| 2025-02-27 | -63.39 |
| 2025-02-26 | -62.36 |
| 2025-02-25 | -62.40 |
| 2025-02-24 | -59.80 |
| 2025-02-21 | -62.23 |
| 2025-02-20 | -61.36 |
| 2025-02-19 | -60.24 |
| 2025-02-18 | -59.68 |
| 2025-02-17 | -62.70 |
| 2025-02-14 | -53.67 |
| 2025-02-13 | -50.64 |
| 2025-02-12 | -50.68 |
| 2025-02-11 | -51.07 |
| 2025-02-10 | -52.07 |
| 2025-02-07 | -46.62 |
| 2025-02-06 | -46.62 |
| 2025-02-05 | -44.24 |
| 2025-01-27 | -42.08 |
| 2025-01-24 | -42.73 |
| 2025-01-23 | -41.48 |
| 2025-01-22 | -40.44 |
| 2025-01-21 | -40.96 |
| 2025-01-20 | -40.70 |
| 2025-01-17 | -41.09 |
| 2025-01-16 | -41.04 |
| 2025-01-15 | -41.00 |
| 2025-01-14 | -41.52 |
| 2025-01-13 | -38.97 |
| 2025-01-10 | -38.10 |
| 2025-01-09 | -39.62 |
| 2025-01-08 | -39.88 |
| 2025-01-07 | -39.92 |
| 2025-01-06 | -39.18 |
| 2025-01-03 | -38.62 |
| 2025-01-02 | -40.74 |
| 2024-12-31 | -42.60 |
| 2024-12-30 | -44.42 |
| 2024-12-27 | -45.50 |
| 2024-12-26 | -45.84 |
| 2024-12-25 | -45.41 |
| 2024-12-24 | -45.24 |
| 2024-12-23 | -44.93 |
| 2024-12-20 | -47.40 |
| 2024-12-19 | -46.19 |
| 2024-12-18 | -46.45 |
| 2024-12-17 | -46.06 |
| 2024-12-16 | -48.95 |